Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula
NDC 17312-477, Candida Albicans, Wood Creosote, Sodium Chloride, Sulphur, tablet, from TRP Company.
- Product NDC
- 17312-477
- Status
- Listed
- Labeler
- TRP Company
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17312-477 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANDIDA ALBICANS30 [hp_X]/1
- WOOD CREOSOTE30 [hp_X]/1
- SODIUM CHLORIDE12 [hp_X]/1
- SULFUR12 [hp_X]/1
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17312-477-30 | 17312047730 | 60 BLISTER PACK in 1 BOX (17312-477-30) / 1 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17312-477 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17312-477 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17312-477. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.